[
  {
    "ticker": "BOT",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967026",
    "id": "02967026",
    "pages": 24,
    "price_sensitive": false,
    "date": "20250708",
    "time": "0830",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkxdtxhvn166.pdf",
    "summary": "<h3>Summary of Material Information:</h3>\n<ul>\n<li><strong>Sofdra\u2122 Launch Performance</strong>:  </li>\n<li><strong>Gross Sales</strong>: ~AUD $25 million cumulative (Jan-Jun 2025), with monthly growth.  </li>\n<li><strong>Prescriptions</strong>: Over 16,000 TRx filled since launch (Feb 2025).  </li>\n<li><strong>Prescriber Base</strong>: 2,300+ unique prescribers in June 2025 (up from 540 in Feb 2025).  </li>\n<li>\n<p><strong>Refill Rates</strong>: Exceeding industry average (3.4 fills per patient vs. 2 fills benchmark).  </p>\n</li>\n<li>\n<p><strong>Gross-to-Net (GTN) Dynamics</strong>:  </p>\n</li>\n<li>GTN yield improved to <strong>23%</strong> (June 2025), target <strong>30\u201340%</strong>.  </li>\n<li>\n<p>Fully reimbursed claims grew <strong>50%</strong> since launch; high-deductible claims declined <strong>75%</strong>.  </p>\n</li>\n<li>\n<p><strong>Commercial Strategy</strong>:  </p>\n</li>\n<li><strong>Sales Force Expansion</strong>: From 27 reps (Q3 2025) to <strong>50 reps</strong> (Q2 2026).  </li>\n<li>\n<p><strong>Demand Drivers</strong>: HCP engagement, digital/media campaigns, peer-reviewed data (JAAD publication).  </p>\n</li>\n<li>\n<p><strong>Benchmark Comparison</strong>:  </p>\n</li>\n<li>Rep productivity (~AUD $81k net revenue/rep) exceeds early-stage peers (e.g., ZORYVE at ~USD $30k/rep).  </li>\n</ul>\n<p><em>No material capital raising, financial results, or trading halt details identified.</em></p>",
    "usage": {
      "prompt_tokens": 5517,
      "completion_tokens": 308,
      "total_tokens": 5825,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-07T22:37:24.190139"
  },
  {
    "ticker": "BOT",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967023",
    "id": "02967023",
    "pages": 4,
    "price_sensitive": true,
    "date": "20250708",
    "time": "0827",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkx61d71dvjg.pdf",
    "summary": "<h3><strong>Summary of ASX Announcement \u2013 Botanix Pharmaceuticals (ASX: BOT)</strong></h3>\n<h4><strong>Sofdra\u2122 Launch Update</strong></h4>\n<ul>\n<li><strong>Gross sales ~AUD $25m</strong> (Jan\u2013Jun 2025)  </li>\n<li><strong>2,300+ unique prescribers</strong> in June 2025  </li>\n<li><strong>16,000+ prescriptions filled</strong> across 6,700 patients (since launch)  </li>\n<li><strong>Refill rates exceed industry average</strong> (3.4 fills vs. 2 for peers)  </li>\n<li><strong>GTN yield at 23%</strong> (targeting 30\u201340%)  </li>\n<li><strong>Salesforce expansion planned</strong>:  </li>\n<li>Current: 33 territories  </li>\n<li>Planned: 50 territories by Q2 FY2026  </li>\n</ul>\n<p><strong>No material information omitted.</strong> (Operational metrics indicate strong launch trajectory but no direct capital/trading implications.)  </p>\n<hr />\n<p><em>Note: No material capital structure changes, trading halts, or liquidity impacts identified.</em></p>",
    "usage": {
      "prompt_tokens": 2435,
      "completion_tokens": 203,
      "total_tokens": 2638,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-07T22:41:44.434672"
  },
  {
    "ticker": "LSF",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967022",
    "id": "02967022",
    "pages": 4,
    "price_sensitive": false,
    "date": "20250708",
    "time": "0827",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkx3y3cwvnh1.pdf",
    "summary": "<h3><strong>Key Material Information Summary</strong></h3>\n<h4><strong>Performance &amp; Positioning:</strong></h4>\n<ul>\n<li><strong>June 2025 Return:</strong> +5.8% (vs. ASX200AI +1.4%).  </li>\n<li><strong>5-Year Annualized Return:</strong> +21.0% p.a. (vs. ASX200AI +11.8% p.a.).  </li>\n<li><strong>Portfolio Positioning:</strong> Strong value skew (median long P/E: 11x, ~8% FCF yield, double-digit EPS growth). Favors infrastructure, gold, copper, travel, and \"quality value\" stocks.  </li>\n</ul>\n<h4><strong>Key Contributors (Long Positions):</strong></h4>\n<ul>\n<li><strong>Santos (+16%):</strong> Non-binding takeover offer at A$8.89/sh (28% premium); Barossa/Pikka projects nearing completion.  </li>\n<li><strong>Viva Energy (+16%):</strong> Recovery in retail fuel margins and volatile refining margins; OTR/Coles Express synergies expected.  </li>\n<li><strong>James Hardie (+18%):</strong> Rebound post-Azek acquisition close; U.S. investor interest renewed.  </li>\n</ul>\n<h4><strong>Key Detractor:</strong></h4>\n<ul>\n<li><strong>Gold Investments:</strong> Pullback after strong 2025 performance; physical gold price consolidation.  </li>\n</ul>\n<h4><strong>Market Outlook:</strong></h4>\n<ul>\n<li>ASX deemed \"fully valued\"; global equities (non-Australian) preferred for growth and valuation upside.  </li>\n</ul>\n<h4><strong>Exposure &amp; Liquidity (30 June 2025):</strong></h4>\n<ul>\n<li><strong>NTA (after tax):</strong> $3.12/share.  </li>\n<li><strong>Market Cap:</strong> $1.82bn.  </li>\n<li><strong>Net Exposure:</strong> 77% (32% North America, 31% Europe).  </li>\n</ul>\n<p><strong>No capital raising or material corporate action identified.</strong></p>",
    "usage": {
      "prompt_tokens": 4736,
      "completion_tokens": 355,
      "total_tokens": 5091,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-07T22:41:09.136799"
  },
  {
    "ticker": "ARU",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967025",
    "id": "02967025",
    "pages": 2,
    "price_sensitive": false,
    "date": "20250708",
    "time": "0827",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkxb6wysqj8s.pdf",
    "summary": "<ul>\n<li><strong>Potential Equity Investment</strong>: German Raw Materials Fund (GRMF) appraisal phase initiated for \u20ac50m\u2013\u20ac150m (target: \u20ac100m / ~A$175m) in Arafura\u2019s Nolans Project, tied to NdPr supply.  </li>\n<li><strong>Key Conditionality</strong>: Investment subject to due diligence, IMC approval, and definitive agreements.  </li>\n<li><strong>Strategic Context</strong>: Complements existing A$200m commitment from Australia\u2019s National Reconstruction Fund and US$115m Euler Hermes loan guarantee.  </li>\n<li><strong>Offtake Link</strong>: \u20ac50m tranche tied to Siemens Gamesa\u2019s 520tpa NdPr supply; additional \u20ac50m sought for 500tpa expansion (subject to approval).  </li>\n</ul>\n<p><em>Omitted: Background on GRMF, process details, non-material partnerships.</em></p>",
    "usage": {
      "prompt_tokens": 1255,
      "completion_tokens": 169,
      "total_tokens": 1424,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-07T22:42:21.293520"
  },
  {
    "ticker": "CTW",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967024",
    "id": "02967024",
    "pages": 1,
    "price_sensitive": false,
    "date": "20250708",
    "time": "0827",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkx83lslgzbj.pdf",
    "summary": "<p><strong>Stop Loss Trigger Event \u2013 CitiFIRST MINIs (Key Details):</strong><br />\n- <strong>GYGKOC (Guzman Y Gomez Ltd):</strong> Stop Loss Level = $27.28 per underlying parcel; Cash Amount = <strong>$4.46 per MINI</strong>.<br />\n- <strong>WGXKOA (Westgold Resources Ltd):</strong> Stop Loss Level = $2.74 per underlying parcel; Cash Amount = <strong>$0.47 per MINI</strong>.<br />\n- <strong>Stop Loss Trading Window:</strong> Bid at Cash Amount available from 2pm day after trigger until 4pm next day.<br />\n- <strong>Expiry:</strong> Unwound MINIs expire post-payment (within 10 business days post-trigger).  </p>\n<p><em>Note: No broader capital markets impact; specific to derivative instrument terms.</em></p>",
    "usage": {
      "prompt_tokens": 635,
      "completion_tokens": 164,
      "total_tokens": 799,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-07T22:38:19.469601"
  },
  {
    "ticker": "THL",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967020",
    "id": "02967020",
    "pages": 2,
    "price_sensitive": false,
    "date": "20250708",
    "time": "0826",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkwzl6147gqn.pdf",
    "summary": "<ul>\n<li><strong>Key Update on North American Tariffs</strong>:  </li>\n<li>Canada issues indefinite Remission Order, eliminating tariffs on RV imports from the USA for thl.  </li>\n<li>Confirmed exemption for thl's RV exports from Canada to the USA, ensuring no tariffs apply.  </li>\n<li><strong>Material Impact</strong>: Removal of tariffs improves cost structure and profitability for thl's North American RV operations.  </li>\n</ul>\n<p>(Excludes boilerplate, background, and non-material details.)</p>",
    "usage": {
      "prompt_tokens": 857,
      "completion_tokens": 93,
      "total_tokens": 950,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-07T22:34:03.958421"
  },
  {
    "ticker": "SNT",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967021",
    "id": "02967021",
    "pages": 2,
    "price_sensitive": false,
    "date": "20250708",
    "time": "0826",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkx1q0vjxddl.pdf",
    "summary": "<ul>\n<li><strong>Material Information</strong>:  </li>\n<li><strong>INN Granted</strong>: WHO assigned the generic name \"amsulostat\" to SNT-5505, signaling global recognition and advancement in clinical development.  </li>\n<li><strong>Clinical Progress</strong>: Phase 2 interim results show promising efficacy/safety for amsulostat in myelofibrosis (combined with ruxolitinib).  </li>\n<li><strong>Regulatory Milestones</strong>: Follows recent FDA Fast Track Designation, reinforcing potential for accelerated development.  </li>\n</ul>\n<p><em>Omitted</em>: Background on company, pipeline details beyond amsulostat, and forward-looking statements (non-material to immediate trading).</p>",
    "usage": {
      "prompt_tokens": 1381,
      "completion_tokens": 127,
      "total_tokens": 1508,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-07T22:35:34.315515"
  },
  {
    "ticker": "BGD",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967019",
    "id": "02967019",
    "pages": 8,
    "price_sensitive": false,
    "date": "20250708",
    "time": "0825",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkwxfthn63h0.pdf",
    "summary": "<ul>\n<li><strong>Security Issuance</strong>:</li>\n<li><strong>Type</strong>: Conversion of options (BGDAW) to ordinary shares (BGD).</li>\n<li><strong>Shares Issued</strong>: 64,568 fully paid ordinary shares.  </li>\n<li><strong>Issue Date</strong>: 08/07/2025.  </li>\n<li><strong>Ranking</strong>: Equally with existing shares.  </li>\n<li>\n<p><strong>Consideration</strong>: Non-cash (employee incentive plan).  </p>\n</li>\n<li>\n<p><strong>Post-Issuance Capital Structure</strong>:  </p>\n</li>\n<li><strong>Total Ordinary Shares on Issue</strong>: 223,274,967 (BGD).  </li>\n<li><strong>Unquoted Options</strong>: Multiple tranches (~16.9m options) with varying expiries and exercise prices.  </li>\n</ul>\n<p>No material trading or valuation impacts identified (routine option conversion).</p>",
    "usage": {
      "prompt_tokens": 1912,
      "completion_tokens": 161,
      "total_tokens": 2073,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-07T22:35:56.831292"
  },
  {
    "ticker": "A1M",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967018",
    "id": "02967018",
    "pages": 13,
    "price_sensitive": true,
    "date": "20250708",
    "time": "0823",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkwtwj34gz5z.pdf",
    "summary": "<ul>\n<li><strong>Drilling Results</strong>: High-grade copper intercepts at Jericho Deposit, including:  </li>\n<li><strong>Jolly Shoot (J1 Lens)</strong>:  <ul>\n<li>7.0m @ 2.4% Cu &amp; 0.4g/t Au  </li>\n<li>6.0m @ 2.4% Cu &amp; 1.8g/t Au  </li>\n<li>7.2m @ 2.8% Cu &amp; 0.5g/t Au (incl. 2.2m @ 7.6% Cu &amp; 1.2g/t Au)  </li>\n</ul>\n</li>\n<li><strong>Tucker Shoot (J2 Lens)</strong>:  <ul>\n<li>3.1m @ 3.0% Cu &amp; 0.4g/t Au  </li>\n<li>6.0m @ 1.8% Cu &amp; 0.6g/t Au  </li>\n</ul>\n</li>\n<li><strong>Implications</strong>: Confirms high-grade mineralization near planned Jericho Link Drive, enhancing potential for early ore development. Mineralization remains open down-plunge.  </li>\n<li><strong>Upcoming</strong>: Additional drilling results expected in coming months.  </li>\n</ul>\n<p><em>Note: No capital markets or trading-specific actions (e.g., raising, halt) identified.</em></p>",
    "usage": {
      "prompt_tokens": 8800,
      "completion_tokens": 252,
      "total_tokens": 9052,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-07T22:39:40.491006"
  },
  {
    "ticker": "LSF",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967017",
    "id": "02967017",
    "pages": 1,
    "price_sensitive": false,
    "date": "20250708",
    "time": "0823",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkwrsr80cnvt.pdf",
    "summary": "<p>Here's the concise extraction of material information from the ASX announcement:  </p>\n<ul>\n<li><strong>NTA Per Share (03 July 2025):</strong>  </li>\n<li><strong>Pre-tax NTA:</strong> $3.3208 per share  </li>\n<li><strong>Post-tax NTA:</strong> $3.1697 per share  </li>\n</ul>\n<p><strong>Notes:</strong><br />\n- Unaudited figures.<br />\n- No material trading or capital markets actions (e.g., capital raising, liquidity event).  </p>\n<p><em>Summary:</em> NTA update only\u2014no actionable capital markets data.</p>",
    "usage": {
      "prompt_tokens": 439,
      "completion_tokens": 107,
      "total_tokens": 546,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-07T22:36:18.004242"
  },
  {
    "ticker": "SFR",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967003",
    "id": "02967003",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250708",
    "time": "0822",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkvtvbj8zfjy.pdf",
    "summary": "<ul>\n<li><strong>Type of Announcement:</strong> Notification of unquoted equity securities issuance (Performance Rights under employee incentive scheme).  </li>\n<li><strong>Security Details:</strong>  </li>\n<li><strong>Code:</strong> SFRAAE (Performance Rights)  </li>\n<li><strong>Quantity Issued:</strong> 21,070  </li>\n<li><strong>Issue Date:</strong> 30/04/2025  </li>\n<li><strong>Vesting:</strong> Each right convertible to one SFR ordinary share subject to conditions.  </li>\n<li><strong>Total Performance Rights Outstanding:</strong> 2,399,079 (SFRAAE).  </li>\n<li><strong>Ordinary Shares Outstanding:</strong> 459,071,860 (SFR).  </li>\n<li><strong>Key Context:</strong> Issued under FY25 Long Term Incentive Plan (no disclosure of material dilution impact).  </li>\n</ul>\n<p><strong>No material trading impact identified</strong> (routine employee incentive issuance, minimal dilution).</p>",
    "usage": {
      "prompt_tokens": 1455,
      "completion_tokens": 169,
      "total_tokens": 1624,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-07T22:36:42.602035"
  },
  {
    "ticker": "PNN",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967016",
    "id": "02967016",
    "pages": 3,
    "price_sensitive": false,
    "date": "20250708",
    "time": "0822",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkwppzscx0vc.pdf",
    "summary": "<h3>Summary of Material Information:</h3>\n<ul>\n<li><strong>JV Milestone Achieved</strong>: Navigate Energy secured foreign shareholder registration approval, enabling JV entity incorporation and transfer of Rincon Lithium Project tenure.  </li>\n<li><strong>Funding Release</strong>: US$4 million investment from Navigate Energy to be released post-incorporation for project development, including a lithium brine pilot plant.  </li>\n<li><strong>Near-Term Action</strong>: Incorporation and first tranche (US$1 million) expected in current quarter.  </li>\n<li><strong>Additional Asset Transfer</strong>: Pocitos Lithium Project to be transferred to the JV post-incorporation, leveraging infrastructure synergies.  </li>\n</ul>\n<p><em>Note: Focused on material capital structure, funding, and project advancement impacts.</em></p>",
    "usage": {
      "prompt_tokens": 1593,
      "completion_tokens": 142,
      "total_tokens": 1735,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-07T22:35:40.874680"
  },
  {
    "ticker": "SFR",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967006",
    "id": "02967006",
    "pages": 4,
    "price_sensitive": false,
    "date": "20250708",
    "time": "0822",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkw10xt1dsqy.pdf",
    "summary": "<ul>\n<li><strong>Type:</strong> Cessation of Securities (Performance Rights)  </li>\n<li><strong>Security Code:</strong> SFRAAE  </li>\n<li><strong>Number Ceased:</strong> 160,709 Performance Rights  </li>\n<li><strong>Reason:</strong> Lapse due to unmet conditions  </li>\n<li><strong>Date of Cessation:</strong> 30/06/2025  </li>\n<li><strong>Remaining Performance Rights Outstanding:</strong> 2,217,300  </li>\n<li><strong>No impact on issued ordinary shares (459,071,860 SFR shares remain outstanding).</strong>  </li>\n</ul>\n<p><em>No material trading or capital markets impact identified (non-dilutive event).</em></p>",
    "usage": {
      "prompt_tokens": 1041,
      "completion_tokens": 119,
      "total_tokens": 1160,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-07T22:37:42.225868"
  },
  {
    "ticker": "ORI",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967015",
    "id": "02967015",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250708",
    "time": "0822",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkwmm7vfpr0y.pdf",
    "summary": "<ul>\n<li><strong>Buy-back Type</strong>: On-market buy-back  </li>\n<li><strong>Total Buy-back Program</strong>: Up to AUD 400 million worth of ordinary shares  </li>\n<li><strong>Buy-back Period</strong>: 28/3/2025 to 27/3/2026 (subject to market conditions)  </li>\n<li><strong>Daily Buy-back (7/7/2025)</strong>:  </li>\n<li>Shares bought: 90,339  </li>\n<li>Total consideration: AUD 1,779,750.57  </li>\n<li>Price range: AUD 19.60 (low) to AUD 19.80 (high)  </li>\n<li><strong>Remaining Capacity</strong>: No explicit limit on shares, but total program capped at AUD 400M  </li>\n<li><strong>Broker</strong>: Goldman Sachs Australia Pty Ltd  </li>\n</ul>\n<p>No material changes to capital structure or liquidity beyond ongoing buy-back execution.</p>",
    "usage": {
      "prompt_tokens": 1578,
      "completion_tokens": 168,
      "total_tokens": 1746,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-07T22:35:31.281237"
  },
  {
    "ticker": "KAR",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967014",
    "id": "02967014",
    "pages": 4,
    "price_sensitive": false,
    "date": "20250708",
    "time": "0822",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkwkkk9tzk0n.pdf",
    "summary": "<h3><strong>Notification of Cessation of Securities \u2013 Karoon Energy Ltd (ASX: KAR)</strong></h3>\n<ul>\n<li><strong>Performance Rights Lapsed:</strong>  </li>\n<li><strong>KARAAD (Expiring 31-Dec-2027):</strong> 29,697 rights ceased (conditions unmet).  </li>\n<li><strong>KARAB (Expiring 31-Dec-2028):</strong> 57,032 rights ceased (conditions unmet).  </li>\n<li><strong>Cessation Date:</strong> 04/07/2025.  </li>\n<li><strong>No material impact on issued capital or liquidity:</strong> Remaining performance rights and ordinary shares (735.2M) unchanged.  </li>\n</ul>\n<p><strong>No material trading/capital markets impact identified.</strong>  </p>\n<p><em>(Note: Routine expiry of performance rights with immaterial volume; no consideration paid.)</em></p>",
    "usage": {
      "prompt_tokens": 1365,
      "completion_tokens": 159,
      "total_tokens": 1524,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-07T22:40:16.140640"
  },
  {
    "ticker": "PTM",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967009",
    "id": "02967009",
    "pages": 1,
    "price_sensitive": true,
    "date": "20250708",
    "time": "0822",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkw77k7wddv6.pdf",
    "summary": "<ul>\n<li><strong>Increased turnaround costs</strong>: FY implementation costs revised to ~$40M (from $30M announced on 7 July 2025), including non-cash share-based payment amortisation.  </li>\n</ul>\n<p><em>(No other material information identified.)</em></p>",
    "usage": {
      "prompt_tokens": 483,
      "completion_tokens": 49,
      "total_tokens": 532,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-07T22:34:13.169877"
  },
  {
    "ticker": "LML",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967013",
    "id": "02967013",
    "pages": 33,
    "price_sensitive": true,
    "date": "20250708",
    "time": "0822",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkwhhcj7f354.pdf",
    "summary": "<h3><strong>Material Information Summary (Exploration Update)</strong></h3>\n<ul>\n<li><strong>High-priority drill targets confirmed</strong> at Minbrie Copper-Base Metals Project, with potential for large-scale mineralization.  </li>\n<li><strong>Key intercepts from historic drilling</strong>:  </li>\n<li><strong>BUDD1921</strong>: 29.5m @ 0.8% Cu, 7.5% Pb, 1.9% Zn, 9.0 g/t Ag.  </li>\n<li><strong>BURCD0301</strong>: High-grade copper veining (up to 3.03% Cu via pXRF).  </li>\n<li><strong>Drilling approvals pending</strong>, expected within two months, with drilling planned for <strong>H2 2025</strong>.  </li>\n<li><strong>3D modelling</strong> supports structural traps and refined targeting.  </li>\n<li><strong>Exploration focus</strong>: Oxide/supergene zones and fresh sulphide mineralisation.  </li>\n</ul>\n<p><strong>No material financial or capital structure impacts identified.</strong></p>",
    "usage": {
      "prompt_tokens": 14792,
      "completion_tokens": 190,
      "total_tokens": 14982,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-07T22:37:11.548840"
  },
  {
    "ticker": "INA",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967010",
    "id": "02967010",
    "pages": 12,
    "price_sensitive": false,
    "date": "20250708",
    "time": "0822",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkw99s6jyn90.pdf",
    "summary": "<ul>\n<li><strong>Substantial Shareholder Notice (Form 603)</strong>: BlackRock entities collectively hold a significant stake in INGENIA COMMUNITIES GROUP (INA).  </li>\n<li><strong>Relevant Interests</strong>:  </li>\n<li>BlackRock holds voting rights via multiple subsidiaries (e.g., BlackRock Advisors UK, BlackRock Investment Management Australia, etc.) through securities lending and collateral arrangements.  </li>\n<li>Total voting rights controlled: <strong>Aggregate undisclosed (details in Annexure A/B)</strong>.  </li>\n<li><strong>Recent Acquisitions</strong>:  </li>\n<li>Multiple on-market purchases between March\u2013July 2025 at prices ranging <strong>AUD 5.24\u20135.78 per share</strong> (Annexure B).  </li>\n<li>Includes collateral transfers and in-specie transactions (e.g., <strong>140,726 shares acquired on 4-Jul-25 at AUD 5.33</strong>).  </li>\n<li><strong>Securities Lending Agreements</strong>:  </li>\n<li>BlackRock entities have active lending agreements with major banks (e.g., JPMorgan, Goldman Sachs) with recall rights (Annexure D).  </li>\n</ul>\n<p><em>No material capital structure changes or liquidity impacts identified beyond the above.</em></p>",
    "usage": {
      "prompt_tokens": 11505,
      "completion_tokens": 237,
      "total_tokens": 11742,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-07T22:36:39.403518"
  },
  {
    "ticker": "XYZ",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967002",
    "id": "02967002",
    "pages": 1,
    "price_sensitive": false,
    "date": "20250708",
    "time": "0822",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkvrs3p1htp8.pdf",
    "summary": "<ul>\n<li><strong>Reporting Person</strong>: Brian Grassadonia (Ecosystem Lead at Block, Inc.)  </li>\n<li><strong>Transaction Type</strong>: Disposal of shares (tax withholding on vested RSUs)  </li>\n<li><strong>Security</strong>: Class A Common Stock  </li>\n<li><strong>Shares Sold</strong>: 1,342  </li>\n<li><strong>Price</strong>: $69.26 per share  </li>\n<li><strong>Date</strong>: July 2, 2025  </li>\n<li><strong>Remaining Ownership</strong>: 590,287 shares (Direct)  </li>\n</ul>\n<p>No other material information identified.</p>",
    "usage": {
      "prompt_tokens": 1422,
      "completion_tokens": 102,
      "total_tokens": 1524,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-07T22:36:13.473160"
  },
  {
    "ticker": "NDO",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967012",
    "id": "02967012",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250708",
    "time": "0822",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkwffp8yvkhs.pdf",
    "summary": "<ul>\n<li><strong>Buy-back Type:</strong> On-market buy-back  </li>\n<li><strong>Total Securities Bought Back Previous Day:</strong> 20,000 (AUD 13,544.87 at avg. ~AUD 0.677/share)  </li>\n<li><strong>Cumulative Buy-back to Date:</strong> 625,949 shares (of 228,069,706 outstanding)  </li>\n<li><strong>Maximum Buy-back Program Size:</strong> 22,566,736 shares (remaining: 21,940,787)  </li>\n<li><strong>Buy-back Period:</strong> 14/3/2025 to 13/3/2026  </li>\n<li><strong>Price Range (Previous Day):</strong> AUD 0.675 (low) \u2013 AUD 0.68 (high)  </li>\n<li><strong>Broker:</strong> MA Moelis Australia Securities Pty Ltd  </li>\n</ul>\n<p><em>No material valuation or liquidity impacts noted beyond routine buy-back execution.</em></p>",
    "usage": {
      "prompt_tokens": 1497,
      "completion_tokens": 176,
      "total_tokens": 1673,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-07T22:36:24.062201"
  },
  {
    "ticker": "RG8",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967011",
    "id": "02967011",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250708",
    "time": "0822",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkwccgdsd28h.pdf",
    "summary": "<ul>\n<li><strong>Type:</strong> Daily buy-back notification (on-market)  </li>\n<li><strong>Total shares bought to date:</strong> 4,750,108  </li>\n<li><strong>Shares bought on previous day (7/7/2025):</strong> 5,088  </li>\n<li><strong>Maximum buy-back target:</strong> 39,486,547 (remaining: 34,731,351)  </li>\n<li><strong>Buy-back period:</strong> 26/11/2024 to 24/11/2025 (estimated)  </li>\n<li><strong>Previous day's buy-back metrics:</strong>  </li>\n<li>Price paid: AUD 2.010000 (flat)  </li>\n<li>Total consideration: AUD 10,226.88000  </li>\n<li>ASX price cap (Rule 7.33): AUD 2.13490000</li>\n</ul>",
    "usage": {
      "prompt_tokens": 1560,
      "completion_tokens": 158,
      "total_tokens": 1718,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-07T22:37:14.456568"
  },
  {
    "ticker": "RMD",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967004",
    "id": "02967004",
    "pages": 3,
    "price_sensitive": false,
    "date": "20250708",
    "time": "0822",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkvwx13k1wy2.pdf",
    "summary": "<ul>\n<li><strong>Form 144 Filing (Insider Sale):</strong>  </li>\n<li><strong>Seller:</strong> Michael J. Farrell (Officer/Director of ResMed Inc.)  </li>\n<li><strong>Securities Sold:</strong> 8,009 common shares (NYSE: RMD)  </li>\n<li><strong>Aggregate Market Value:</strong> ~$2.06M AUD (converted from USD)  </li>\n<li><strong>Approximate Sale Date:</strong> 07/07/2025 (planned)  </li>\n<li><strong>Recent Sales (Past 3 Months):</strong>  <ul>\n<li>08/07/2025: 8,009 shares ($1.68M)  </li>\n<li>05/07/2025: 8,009 shares ($1.95M)  </li>\n<li>06/09/2025: 8,009 shares ($2.01M)  </li>\n</ul>\n</li>\n<li><strong>Rule 10b5-1 Plan:</strong> Adopted 10/31/2024 (prearranged trading plan)  </li>\n</ul>\n<p><em>Note: Filing indicates no undisclosed material adverse information about ResMed as of the plan adoption date.</em></p>",
    "usage": {
      "prompt_tokens": 1327,
      "completion_tokens": 225,
      "total_tokens": 1552,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-07T22:38:05.802748"
  },
  {
    "ticker": "KAR",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967008",
    "id": "02967008",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250708",
    "time": "0822",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkw55bj1wqhh.pdf",
    "summary": "<ul>\n<li><strong>Buy-back Type</strong>: On-market buy-back  </li>\n<li><strong>Total Shares Bought Back</strong>: 17,125,347 (before previous day) + 296,880 (on previous day) = <strong>17,422,227</strong>  </li>\n<li><strong>Total Consideration Paid</strong>: AUD 27,719,477.53 (before) + AUD 562,118.80 (on previous day) = <strong>AUD 28,281,596.33</strong>  </li>\n<li><strong>Maximum Buy-back Cap</strong>: 20,800,000 shares (remaining: <strong>3,377,773</strong> as of 7/7/2025)  </li>\n<li><strong>Price Range</strong>: AUD 1.28 (low) to AUD 2.12 (high)  </li>\n<li><strong>Buy-back Period</strong>: 17/4/2025 to 17/4/2026  </li>\n<li><strong>USD Equivalent</strong>: ~USD 22 million intended for buy-back</li>\n</ul>",
    "usage": {
      "prompt_tokens": 1526,
      "completion_tokens": 190,
      "total_tokens": 1716,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-07T22:37:52.342574"
  },
  {
    "ticker": "XYZ",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967005",
    "id": "02967005",
    "pages": 1,
    "price_sensitive": false,
    "date": "20250708",
    "time": "0822",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkvyz73c9k3g.pdf",
    "summary": "<ul>\n<li><strong>Name &amp; Role</strong>: Owen Britton (Business Lead, Block Inc.)  </li>\n<li><strong>Transaction</strong>: Disposal of 1,050 Class A Common Shares via automatic sell-to-cover for tax withholding (RSU vesting)  </li>\n<li><strong>Price</strong>: $69.26 per share  </li>\n<li><strong>Post-Transaction Holdings</strong>: 277,924 shares (direct ownership)  </li>\n<li><strong>Date</strong>: 07/02/2025  </li>\n</ul>\n<p><em>No material trading or capital markets impact identified (routine insider transaction).</em></p>",
    "usage": {
      "prompt_tokens": 1419,
      "completion_tokens": 104,
      "total_tokens": 1523,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-07T22:34:00.819837"
  },
  {
    "ticker": "VG1",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967007",
    "id": "02967007",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250708",
    "time": "0822",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkw333pvhq03.pdf",
    "summary": "<ul>\n<li><strong>Buy-back Type</strong>: On-market buy-back  </li>\n<li><strong>Total Securities on Issue</strong>: 269,446,959  </li>\n<li><strong>Maximum Securities to be Bought Back</strong>: 67,382,076 (remaining: 52,817,879 as of 7/7/2025)  </li>\n<li><strong>Buy-back Period</strong>: Estimated 26/11/2024 to 24/11/2025  </li>\n<li><strong>Daily Buy-back Activity (7/7/2025)</strong>:  </li>\n<li><strong>Securities Bought</strong>: 20,256  </li>\n<li><strong>Consideration Paid</strong>: AUD 36,110.70  </li>\n<li><strong>Price Range</strong>: AUD 1.780\u20131.805  </li>\n<li><strong>Historical Cumulative Buy-back</strong>:  </li>\n<li><strong>Total Securities Bought</strong>: 14,543,941  </li>\n<li><strong>Total Consideration</strong>: AUD 25,450,674.07  </li>\n<li><strong>Historical Price Range</strong>: AUD 1.400\u20132.030  </li>\n<li><strong>Broker</strong>: Third Party Platform Pty Ltd  </li>\n<li><strong>Shareholder Approval Required</strong>: Yes (Ordinary resolution, meeting anticipated 25/11/2024)  </li>\n</ul>\n<p><em>No further material information identified.</em></p>",
    "usage": {
      "prompt_tokens": 1568,
      "completion_tokens": 244,
      "total_tokens": 1812,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-07T22:41:31.826021"
  },
  {
    "ticker": "DVP",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967000",
    "id": "02967000",
    "pages": 7,
    "price_sensitive": false,
    "date": "20250708",
    "time": "0821",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkvmn7h33c8w.pdf",
    "summary": "<p>Here is the concise summary of material information from the ASX announcement:</p>\n<ul>\n<li><strong>Substantial Shareholder Notice (BlackRock Group)</strong>:  </li>\n<li>Total voting power: <strong>18,053,223 shares</strong> (aggregate of BlackRock entities)  </li>\n<li>Key acquisitions: Majority acquired via on-market purchases at prices ranging from <strong>A$2.59 to A$5.08</strong> (Mar-Jul 2025), with <strong>3,333,333 shares</strong> acquired in-specie by BlackRock UK on 3-Jul-25.  </li>\n<li>Largest holdings: BlackRock Investment Management (UK) Limited (<strong>10.23M shares</strong>) and BlackRock Investment Management (Australia) Limited (<strong>929,823 shares</strong>).  </li>\n</ul>\n<p><em>No other material information (capital structure changes, trading halt, or corporate actions) identified.</em>  </p>\n<p><strong>Summary tailored for trading/capital markets relevance</strong>: Focuses on scale of ownership, acquisition prices, and liquidity impact. Excludes legal/boilerplate details.</p>",
    "usage": {
      "prompt_tokens": 6262,
      "completion_tokens": 206,
      "total_tokens": 6468,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-07T22:34:33.773309"
  },
  {
    "ticker": "XYZ",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02966999",
    "id": "02966999",
    "pages": 1,
    "price_sensitive": false,
    "date": "20250708",
    "time": "0821",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkvkl09t0zwf.pdf",
    "summary": "<ul>\n<li><strong>Reporting Person</strong>: Dale Ajmere, Chief Accounting Officer of Block, Inc.  </li>\n<li><strong>Transaction Type</strong>: Disposal of shares (Sale)  </li>\n<li><strong>Security</strong>: Class A Common Stock  </li>\n<li><strong>Date</strong>: 07/02/2025  </li>\n<li><strong>Shares Sold</strong>: 366 (to cover tax withholding on RSU vesting)  </li>\n<li><strong>Sale Price</strong>: $69.26 per share  </li>\n<li><strong>Post-Transaction Ownership</strong>: 108,736 shares (Direct)  </li>\n</ul>\n<p><em>No other material trading or capital markets information identified.</em></p>",
    "usage": {
      "prompt_tokens": 1419,
      "completion_tokens": 111,
      "total_tokens": 1530,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-07T22:36:52.605844"
  },
  {
    "ticker": "AAI",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02966998",
    "id": "02966998",
    "pages": 2,
    "price_sensitive": false,
    "date": "20250708",
    "time": "0821",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkvhhsp9f52r.pdf",
    "summary": "<p>No material information identified.  </p>\n<p>(Note: The provided text appears to be corrupted or contains non-readable characters, making it impossible to extract meaningful material information relevant to trading or capital markets decisions.)</p>",
    "usage": {
      "prompt_tokens": 3590,
      "completion_tokens": 39,
      "total_tokens": 3629,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-07T22:36:20.347048"
  },
  {
    "ticker": "NGY",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02966997",
    "id": "02966997",
    "pages": 2,
    "price_sensitive": false,
    "date": "20250708",
    "time": "0821",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkvffkv56nny.pdf",
    "summary": "<p><strong>Summary of Material Information:</strong></p>\n<ul>\n<li><strong>Operational Update:</strong> Spudding commenced for second CBM well (TE-B06002) under Early Gas Sales Initiative (target: 1 mmscfd initial gas sales).  </li>\n<li><strong>Progress:</strong> Follows completion of first well (TE-B06001); aligns with goal of becoming Indonesia\u2019s first commercial CBM producer.  </li>\n<li><strong>Technical Details:</strong>  </li>\n<li>Vertical drilling to 416m, targeting coal seams (245\u2013370m depth).  </li>\n<li>\"Open hole\" completion method used for optimal gas recovery.  </li>\n<li>Proximity to TE-B06001 to enhance reservoir connectivity.  </li>\n</ul>\n<p><em>No material trading or capital markets impact identified.</em></p>",
    "usage": {
      "prompt_tokens": 1013,
      "completion_tokens": 145,
      "total_tokens": 1158,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-07T22:41:17.597320"
  },
  {
    "ticker": "XYZ",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967001",
    "id": "02967001",
    "pages": 1,
    "price_sensitive": false,
    "date": "20250708",
    "time": "0821",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkvppxpvkkb1.pdf",
    "summary": "<ul>\n<li><strong>Reporting Person</strong>: Esperanza Chrysty (Chief Legal Officer of Block, Inc.)  </li>\n<li><strong>Transaction Date</strong>: 07/02/2025  </li>\n<li><strong>Transaction Type</strong>: Disposal (D) of <strong>130,821 shares</strong> of Class A Common Stock  </li>\n<li><strong>Price</strong>: $69.26 per share  </li>\n<li><strong>Reason</strong>: Automatic sale to cover tax withholding obligations from vesting of restricted stock units.  </li>\n</ul>\n<p><strong>No other material information identified.</strong></p>",
    "usage": {
      "prompt_tokens": 1423,
      "completion_tokens": 95,
      "total_tokens": 1518,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-07T22:41:57.377829"
  },
  {
    "ticker": "HGH",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02966955",
    "id": "02966955",
    "pages": 4,
    "price_sensitive": false,
    "date": "20250708",
    "time": "0730",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkr9ghn4m9jt.pdf",
    "summary": "<ul>\n<li><strong>Cessation Type</strong>: Performance Rights lapsed (HGHAA)  </li>\n<li><strong>Quantity</strong>: 96,582 securities  </li>\n<li><strong>Reason</strong>: Failure to meet vesting conditions due to participant's employment cessation  </li>\n<li><strong>Date of Cessation</strong>: 03/04/2025  </li>\n<li><strong>No material impact on issued capital</strong> (remaining HGHAA: 1,149,148).  </li>\n</ul>\n<p><em>No material trading or capital structure implications identified.</em></p>",
    "usage": {
      "prompt_tokens": 1098,
      "completion_tokens": 94,
      "total_tokens": 1192,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-07T22:12:22.736869"
  },
  {
    "ticker": "SNZ",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02966954",
    "id": "02966954",
    "pages": 2,
    "price_sensitive": true,
    "date": "20250708",
    "time": "0730",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkr7bp779s0r.pdf",
    "summary": "<h3><strong>Summerset Group Holdings Limited \u2013 2Q25 Sales Metrics (8 July 2025)</strong></h3>\n<h4><strong>Key Material Information:</strong></h4>\n<ul>\n<li><strong>Sales Performance (2Q25):</strong>  </li>\n<li><strong>Total sales:</strong> <strong>402</strong> (222 new, 180 resales) \u2013 <strong>highest quarter ever</strong>.  </li>\n<li><strong>1H25 total sales:</strong> <strong>692</strong> (up <strong>18% YoY</strong> vs. 1H24).  </li>\n<li><strong>Regional diversification:</strong> <strong>46.7% of sales outside Auckland/Wellington/Christchurch</strong>.  </li>\n<li>\n<p><strong>Increased contracted sales:</strong> New uncontracted stock <strong>\u21936%</strong>, contracted new stock <strong>\u219150%</strong>.  </p>\n</li>\n<li>\n<p><strong>Project Updates:</strong>  </p>\n</li>\n<li><strong>St Johns Village (flagship):</strong>  <ul>\n<li><strong>50% of apartments &amp; 60% of memory care units</strong> delivered in late 2024 now <strong>contracted/occupied</strong> (ahead of internal budget).  </li>\n</ul>\n</li>\n<li>\n<p><strong>Development pipeline:</strong> On track to deliver <strong>650\u2013730 homes in FY25</strong>, including village centers in <strong>Cambridge (NZ)</strong>, <strong>Cranbourne North (Australia)</strong>, and first villas at <strong>Chirnside Park (Australia)</strong>.  </p>\n</li>\n<li>\n<p><strong>Next Reporting Date:</strong> <strong>HY25 results on 28 August 2025</strong>.  </p>\n</li>\n</ul>\n<p>No material capital markets actions (e.g., trading halt, capital raising) identified.</p>",
    "usage": {
      "prompt_tokens": 1287,
      "completion_tokens": 288,
      "total_tokens": 1575,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-07T22:12:18.016380"
  }
]